Mylan to challenge court decision over generic asthma, COPD drug – Drug Store News

Mylan to challenge court decision over generic asthma, COPD drug
Drug Store News
in the US District Court for the District of Delaware when the latter sought to market a generic version of Sunovion's Xopenex (levalbuterol hydrochloride) inhalation solution, a drug for asthma and chronic obstructive pulmonary disease.
Mylan to fight $18M patent infringement rulingPittsburgh Business Times

all 4 news articles »

View full post on asthma – Google News

Novartis and IBM announce winners of NCD Challenge – Zenopa

Novartis and IBM announce winners of NCD Challenge
Zenopa
system," said Katherine Holland, general manager of global life sciences at IBM. According to data from the World Health Organization, NCDs such as heart disease, stroke, asthma and cancer contribute to more than 60 percent of deaths around the world.
University Teams Tap Mobile Phones and Social Networks to Fight Non MarketWatch (press release)

all 12 news articles »

View full post on asthma – Google News

Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge … – Sacramento Bee

Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge
Sacramento Bee
ARIDOL, the only dry powder bronchial challenge test approved for use in the United States, is used to assess bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. ARIDOL should not be used as

and more »

View full post on asthma – Google News

Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge … – PR Newswire (press release)

Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge
PR Newswire (press release)
ARIDOL, the only dry powder bronchial challenge test approved for use in the United States, is used to assess bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. ARIDOL should not be used as

and more »

View full post on asthma – Google News

Pfizer wins right to challenge Prempro damages award; Asthma market flat until … – FiercePharma

Pfizer wins right to challenge Prempro damages award; Asthma market flat until
FiercePharma
Item > The asthma drug market will remain flat at around $14.4 billion through 2020, thanks in part to generic rivals for Merck's ($MRK)Singulair, Decision Resources concludes. Release > Teva Pharmaceutical Industries ($TEVA) won an appeals court's

View full post on asthma – Google News

Surviving the back-to-school asthma and allergy challenge – Lincoln Journal Star

Surviving the back-to-school asthma and allergy challenge
Lincoln Journal Star
Right after school begins, when kindergartners and first-graders pull out their mats and rugs at quiet time, there is a spate of dust-induced asthma and rhinitis, say the authors of "Asthma, Allergies, Children: A Parent's Guide.
Back-to-school brings boom in asthma attacks, hospital visits, experts saymysask.com (press release)

all 8 news articles »

View full post on asthma – Google News